Embolism Following IVF: Does Fresh or Frozen-Thawed Transfer Matter?
BACKGROUND AND PURPOSE:
Olausson et al. (Journal of Thrombosis Haemostasis, 2020) compared the incidence of VTE and PE during the first trimester of IVF pregnancies using fresh or frozen-thawed embryo transfer to those of natural pregnancies
Population-based cohort study (1992 to 2012)
National registries (Sweden) that covers 97% to 99.5% of all deliveries
Nulliparous | Ages 15 to 50 years
IVF with fresh embryo transfer
IVF with frozen-thawed embryo transfer
Authors calculated incidences of VTE and PE and estimated time-varying hazard ratio (HR) for all trimesters after fresh or frozen-thawed embryo transfer IVF compared to natural conception
Venous thromboembolism and pulmonary embolism in first trimester
902,891 women included
IVF total: 3.5%
Fresh transfer: 25,382 women | Median age 33.6 years
Frozen-thawed transfer: 4946 women | Median age 34.1 years
Natural conception: 872,563 | 28 years
Fresh embryo transfer as associated with an increased incidence of
VTE: Hazard ratio (HR) 8.96 (95% CI, 6.33 to 12.67)
PE: HR 8.69 (95% CI, 3.83 to 19.71)
The incidence of thromboembolic events following frozen-thawed embryo transfer was not increased during the first trimester
Compared to natural conception, fresh embryo transfer had a more than eightfold increased incidence of VTE and PE in the first trimester
The authors suggest that frozen-thawed embryo transfer may be the preferred method of IVF embryo transfer to reduce maternal risk
In addition, the authors recommend that
…thromboprophylaxis could also be considered during early pregnancy after IVF with fresh embryo transfer
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan